Inventiva (IVA) Other Working Capital Changes (2019 - 2025)
Inventiva (IVA) posted quarterly Other Working Capital Changes of $1.1 million for Q2 2025, up 124.08% year-over-year from $512227.1 in Q2 2024, and up 181.56% quarter-over-quarter from -$1.4 million in Q4 2024.
Inventiva (IVA) Other Working Capital Changes (2019 - 2025) Analysis & Trends
Inventiva's Other Working Capital Changes history runs 7 years deep, the most recent figure standing at $1.1 million for Q2 2025.
- In Q2 2025, Other Working Capital Changes rose 124.08% year-over-year to $1.1 million; the TTM figure through Jun 2025 stood at -$5.1 million (up 52.44% YoY), while the FY2024 annual figure was -$1.4 million, up 18.86% from the prior year.
- Other Working Capital Changes for Q2 2025 stood at $1.1 million, up from -$1.4 million in the prior quarter.
- The five-year high for Other Working Capital Changes was $2.1 million in Q1 2021, with the low at -$2.6 million in Q2 2024.
- The 4-year median for Other Working Capital Changes is $165590.9 (2020), against an average of -$252071.4.
- Peak annual rise in Other Working Capital Changes reached 206.02% in 2021, while the deepest fall reached 6566.33% in 2021.
- Inventiva's Other Working Capital Changes stood at -$4.4 million in 2021, then climbed by 24.28% to -$3.4 million in 2022, then soared by 48.23% to -$1.7 million in 2023, then gained by 18.86% to -$1.4 million in 2024, then soared by 181.56% to $1.1 million in 2025.
- Business Quant data shows IVA's Other Working Capital Changes at $1.1 million in Q2 2025, -$1.4 million in Q4 2024, and -$4.8 million in Q2 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Inventiva | 888.89 Mn | 888.89 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 1.15 Mn |
| Jun 30, 2025 | 1.15 Mn |
| Jun 30, 2025 | 1.15 Mn |
| Dec 31, 2024 | -1.41 Mn |
| Dec 31, 2024 | -1.41 Mn |
| Dec 31, 2024 | -1.41 Mn |
| Jun 30, 2024 | -4.77 Mn |
| Jun 30, 2024 | -4.77 Mn |
| Jun 30, 2024 | -4.77 Mn |
| Dec 31, 2023 | -1.73 Mn |
| Dec 31, 2023 | -1.73 Mn |
| Dec 31, 2023 | -1.73 Mn |
| Jun 30, 2023 | -769,869.55 |
| Jun 30, 2023 | -769,869.55 |
| Jun 30, 2023 | -769,869.55 |
| Dec 31, 2022 | -3.35 Mn |
| Dec 31, 2022 | -3.35 Mn |
| Dec 31, 2022 | -3.35 Mn |
| Sep 22, 2022 | 1.91 Mn |
| Sep 22, 2022 | 1.91 Mn |